查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1447631

週边静脉导管市场-按产品（短PIVC、整合/闭合PIVC）、技术（传统PIVC、安全PIVC）、管腔（单腔、双腔、多腔）、最终用途（医院、门诊手术中心）-全球预测, 2024-2032

Peripheral Intravenous Catheters Market-By Product (Short PIVC, Integrated/Closed PIVC), Technology (Conventional PIVC, Safety PIVC), Lumen (Single, Double, Multi-lumen), End-use (Hospitals, Ambulatory Surgical Centers)-Global Forecast, 2024-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 120 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于在医疗领域引入利用导管系统的支援设备，全球週边静脉导管市场规模预计 2024 年至 2032 年间CAGR将达到 7.7%。大量创新技术正在补充週边静脉导管 (PIVC)，增强其在各种医疗手术中的功能和功效。例如，2023 年 10 月，Linear Health Sciences 的医疗器材 Orchid SRV 安全释放阀获得了 FDA 的扩大适应症。此扩充允许 Orchid SRV 与所有 IV 存取方法一起使用。

随着优化导管插入、固定和维护的先进设备的开发，医疗保健提供者正在提高患者的舒适度和安全性，同时确保可靠的静脉通路。支持技术在医疗领域的不断渗透也将勾勒出产业的扩张。

整个週边静脉导管产业分为产品、技术、管腔、最终用途和区域。

基于技术，从 2024 年到 2032 年，传统 PIVC 领域的市场份额将创下 7.4% 的CAGR。这些导管广泛用于医疗保健环境中的短期静脉治疗，成为患者护理的关键。随着设计和材料的进步，传统的 PIVC 提供了改进的插入技术和患者舒适度。它们的多功能性和可靠性使它们对于各种医疗程序至关重要。随着医疗机构优先考虑病患安全和效率，对传统 PIVC 领域的需求将持续成长。

2024 年至 2032 年，来自门诊手术中心最终用途部分的外周静脉导管市场收入的复合CAGR将达到8.6%。随着门诊手术中心(ASC) 越来越多地执行门诊手术，对可靠、高效的静脉通路的需求已变得至关重要。週边静脉导管有助于在这些中心的手术和诊断过程中安全、方便地输送药物和液体。 ASC 也优先考虑具有成本效益和微创的解决方案，进一步推动产品需求。

2024年至2032年，欧洲週边静脉导管产业的CAGR将达到7.1%。欧洲医院和诊所高度重视医疗技术的进步，正在寻求可靠且多功能的周边静脉导管来简化静脉治疗程序。随着人口老化和医疗基础设施的不断发展，对创新导管解决方案的需求日益增长，以提高患者的舒适度并降低併发症的风险。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 慢性病盛行率增加
      • 静脉注射疗法的需求增加
      • 导管技术进步
      • 过渡到微创外科手术
    • 产业陷阱与挑战
      • 导管相关感染的风险和併发症
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 波特的分析
  • PESTEL分析
  • 报销场景
  • 未来市场趋势

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按产品分类，2018 年 - 2032 年

  • 主要趋势
  • 短週边静脉导管
  • 整合/封闭式 PIVC

第 6 章：市场估计与预测：按技术划分，2018 年 - 2032 年

  • 主要趋势
  • 传统週边静脉导管
  • 安全週边静脉导管

第 7 章：市场估计与预测：按 Lumen，2018 - 2032 年

  • 主要趋势
  • 单腔
  • 双腔
  • 多重腔

第 8 章：市场估计与预测：按最终用途，2018 - 2032 年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 其他最终用户

第 9 章：市场估计与预测：按地区划分，2018 年 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 10 章：公司简介

  • AngioDynamics, Inc.
  • Becton, Dickinson and Company
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • ICU Medical, Inc.
  • Lineus Medical
  • MedSource Labs
  • Retractable Technologies Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • VOGT Medical
  • Vygon
简介目录
Product Code: 7984

Global Peripheral Intravenous Catheters Market size is expected to record 7.7% CAGR between 2024 and 2032 due to the introduction of supportive devices utilizing catheter systems in the medical sector. The influx of innovations is complementing peripheral intravenous catheters (PIVC) with enhanced functionality and efficacy in various medical procedures. For instance, in October 2023, a medical device, Orchid SRV safety release valve from Linear Health Sciences received expanded FDA indication. This expansion allowed Orchid SRV to be utilized with all IV access methods.

With the development of advanced devices that optimize catheter insertion, securement, and maintenance, healthcare providers are improving patient comfort and safety while ensuring reliable intravenous access. The rising penetration of supportive technologies in the medical sector will also outline the industry expansion.

The overall peripheral intravenous catheters industry is segmented into product, technology, lumen, end-use, and region.

Based on technology, the market share from the conventional PIVC segment will record 7.4% CAGR from 2024 to 2032. These catheters are widely used in healthcare settings for short-term intravenous therapy, emerging pivotal for patient care. With advancements in design and materials, conventional PIVCs offer improved insertion techniques and patient comfort. Their versatility and reliability make them essential for various medical procedures. With healthcare facilities prioritizing patient safety and efficiency, the demand for conventional PIVC segment will continue to rise.

Peripheral intravenous catheters market revenue from the ambulatory surgical centers end-use segment will register 8.6% CAGR from 2024 to 2032. With ambulatory surgical centers (ASCs) increasingly performing outpatient procedures, the need for reliable and efficient intravenous access has become paramount. PIVCs facilitate the safe and convenient delivery of medications and fluids during surgical and diagnostic procedures in these centers. ASCs are also prioritizing cost-effective and minimally invasive solutions, further driving the product demand.

Europe peripheral intravenous catheters industry will record 7.1% CAGR from 2024 to 2032. With a strong focus on advancing medical technology, European hospitals and clinics are seeking reliable and versatile PIVCs to streamline intravenous therapy procedures. With the presence of an aging population and evolving healthcare infrastructure, there is an increasing need for innovative catheter solutions that offer improved patient comfort and reduced risk of complications.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast calculations
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of chronic diseases
      • 3.2.1.2 Rise in demand for intravenous therapies
      • 3.2.1.3 Technological advancements in catheters
      • 3.2.1.4 Transitioning to minimally invasive surgical procedures
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Risks and complications of catheter-associated infections
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis
  • 3.8 Reimbursement scenario
  • 3.9 Future market trends

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Short PIVC
  • 5.3 Integrated/closed PIVC

Chapter 6 Market Estimates and Forecast, By Technology, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Conventional PIVC
  • 6.3 Safety PIVC

Chapter 7 Market Estimates and Forecast, By Lumen, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Single lumen
  • 7.3 Double lumen
  • 7.4 Multi-lumen

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Ambulatory surgical centers
  • 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 AngioDynamics, Inc.
  • 10.2 Becton, Dickinson and Company
  • 10.3 B. Braun Melsungen AG
  • 10.4 Boston Scientific Corporation
  • 10.5 ICU Medical, Inc.
  • 10.6 Lineus Medical
  • 10.7 MedSource Labs
  • 10.8 Retractable Technologies Inc.
  • 10.9 Teleflex Incorporated
  • 10.10 Terumo Corporation
  • 10.11 VOGT Medical
  • 10.12 Vygon